The Predicting Effect of ASXL1 Mutation on BCR-ABL Transcript Types and Responses to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia. (2025). Medical Forum Monthly, 36(8). https://doi.org/10.60110/medforum.360805